Show
Sort by
-
Biochemical assessment of bone turnover and bone fragility in men
-
Changes in bone mineral density following discontinuation or continuation of alendronate therapy in glucocorticoid-treated patients - A retrospective, observational study
-
The use of placebo-controlled and non-inferiority trials for the evaluation of new drugs in the treatment of postmenopausal osteoporosis.
-
Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids - A randomized, double-blind, placebo-controlled extension trial.
-
A dose-ranging trial of a matrix transdermal 17b-estradiol for the prevention of bone loss in early postmenopausal women.
-
Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis.